PS7.5: Use of encapsulated engineered human cells for vaccine delivery.
Trisha Fabijanic(University of Arizona), Klearchos K. Papas(University of Arizona), Omid Veiseh(Rice University), Robert C. Johnson(University of Notre Dame), Charles W. Putnam, Anthony J. Davis(Southwestern Medical Center), Carola G Davila(University of Arizona), H. Hagen(University of Arizona), Scott Ajax(University of Arizona), Cole A Mobberly(University of Arizona), Nathan A Fielder(University of Arizona), Amy C. Kelly(University of Arizona), Kelly M Pasowisty(University of Arizona), Thomas Loudovaris(University of Arizona)
Cited by 0
Related Papers
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
|Advanced Drug Delivery Reviews|2009|1.8k
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
|Nature Materials|2015|895
Electrospun chitosan-based nanofibers and their cellular compatibility
|Biomaterials|2005|888
Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice
|Nature Medicine|2016|708
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628